S'abonner

Case-series analysis of haematological malignancies in gold mining areas in South Africa - 05/07/18

Doi : 10.1016/j.respe.2018.05.135 
A. Danjou a, , T. Inamasu a, M. Patel b, C. Espina a, A. Pentz c, M. Joffe c
a Section of Environment and Radiation, International agency for Research on Cancer, Lyon, France 
b MRC/Wits Development Pathways to Health Research Unit, University of Witwatersrand, Johannesburg, South Africa 
c Mine Water Re-Search Group, Geography and Environmental Studies, North-West University, Vanderbijlpark, South Africa 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Introduction

South Africa has a long history of uranium (U) production from gold mining and milling that has resulted in locally high-levels of environmental contamination from uranium and its decay products (radium 226 and radon 222). Due to short distances from mining tailings to residential areas, populations living around gold mine tailings of the Witwatersrand goldfields may be exposed to uranium and its decay products from the tailings through multiple pathways, including ingestion of contaminated water and food grown in contaminated areas, direct consumption of soil (geophagia) and inhalation of dust, raising concern about potential health risks associated with environmental U-exposure, and in particular regarding haematological malignancies (HM). We designed a case-series study of HM from Chris Hani Baragwanath Academic Hospital (CHBAH), South Africa, to assess the feasibility of an analytical study on the association between U-exposure and HM risk in this setting.

Methods

First, patient and cancer characteristics and spatial distribution were retrospectively reviewed from patient files of the HM cases diagnosed between 2004 and 2013 at CHBAH. Spatial relations between residential addresses of patients and location of mine tailings and other U-sources were analysed using a specifically designed GIS-supported virtual geographical environment. Then, we assessed the feasibility of collecting additional information, from patients newly diagnosed with a HM at CHBAH (in 2014–2015), on potential environmental U-exposure pathways and referral patterns from interviewer-administered questionnaires.

Results

Among the 1880 cases aged 18–94 years and retrospectively identified from CHBAH's patient files, 44% were diagnosed with Non-Hodgkin lymphoma (NHL), 26% with leukemia and 17% with myeloma. Referral from distant provinces was not uncommon but more than 90% of patients lived within 50km of the hospital. Human immunodeficiency virus (HIV) status was known for 94%, of which 44% were HIV-positive. No clear and consistent spatial relations between patient's residences and mine tailings deposits could be established. A total of 196 haematological cancer cases aged 18–90 were prospectively diagnosed between 2014 and 2015 at CHBAH, with NHL (35%), leukemia (34%) and myeloma (16%). HIV status was available for all patients, 41% being HIV-positive. Working in gold mines was reported by 12 cases (6%), all men. Soil consumption was a habit for 53 cases (27%), mostly women, and came from backyards and road vendors. Soil consumption occurred more frequently during adulthood and pregnancy. Drinking water came from piped water; untreated water from nearby rivers was not drunk. Animal products and vegetables came from stores and backyards. At the time of interview, 95% of cases were living in Gauteng Province, in Soweto (58%). Half of the cases were living at their current residence for 20 years or more. Cases were referred to CHBAH by governmental clinic doctors (44%), referral hospitals (25%) and private doctors (20%). Most cases lived less than one hour from CHBAH (77%).

Conclusions

This case-series analysis showed the capacity of CHBAH to recruit HM patients and allowed the description of the HM burden of the area. Caution is required when interpreting the spatial distributions of patients; our results may not reflect population-incidence rates due to referral patterns to the hospital and inaccuracies in residential addresses retrospectively collected from clinical records. This needs to be considered when analyzing spatial relations related to various exposure pathways. The questionnaire administered to the prospective cases allowed collecting information on U-related exposure, although results generally showed low exposure prevalence in our study population. As infections, such as HIV, may be a risk factor for some HM, collecting clinical data on infections and subtypes of HM needs to be considered in the investigation of HM risk.

Le texte complet de cet article est disponible en PDF.

Plan


© 2018  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 66 - N° S5

P. S287 - juillet 2018 Retour au numéro
Article précédent Article précédent
  • Initial management of patients with colon cancer according to the presentation in multidisciplinary team meeting and socioeconomic conditions in the Gironde and the Tarn departments in 2010, France
  • A.-S. Foucan, P. Grosclaude, V. Bousser, E. Bauvin, S. Mathoulin-Pelissier, B. Amadeo, G. Coureau
| Article suivant Article suivant
  • Epidemiological, clinical and pathological characteristics of gastric neoplasms. The experience of the first population-based specialized gastric cancer registry in Italy
  • B.M. Donida, G. Tomasello, M. Ghidini, L. Toppo, G. Sabadini, L. Pergola, F. Buffoli, M. Ungari, R. Passalacqua

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.